DNA-methylation profiling distinguishes malignant melanomas from benign nevi

por Conway, Kathleen, Edmiston, Sharon N, Khondker, Zakaria S, Groben, Pamela A, Zhou, Xin, Chu, Haitao, Kuan, Pei Fen, Hao, Honglin, Carson, Craig, Berwick, Marianne, Olilla, David W, Thomas, Nancy E
Publicado 2011

Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1

por Poran, Asaf, Scherer, Julian, Bushway, Meghan E., Besada, Rana, Balogh, Kristen N., Wanamaker, Amy, Williams, Reid G., Prabhakara, Jasmina, Ott, Patrick A., Hu-Lieskovan, Siwen, Khondker, Zakaria S., Gaynor, Richard B., Rooney, Michael S., Srinivasan, Lakshmi
Publicado 2020

Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial

por Li, Jingxin, Hui, Ai-Min, Zhang, Xiang, Ge, Lei, Qiu, Yuanzheng, Tang, Rong, Ye, Huayue, Wang, Xiyuan, Lin, Mei, Zhu, Zhongkui, Zheng, Jianfei, Qiu, Jingjun, Lagkadinou, Eleni, Shpyro, Svetlana, Ozhelvaci, Orkun, Türeci, Özlem, Khondker, Zakaria, Yin, Wanrong, Shishkova, Yoana, Jia, Siyue, Pan, Hongxing, Peng, Fuzhong, Ma, Zhilong, Wu, Zhenggang, Guo, Xiling, Shi, Yunfeng, Muik, Alexander, Şahin, Uğur, Zhu, Li, Zhu, Fengcai
Publicado 2022

Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial

por Hui, Ai-Min, Li, Jingxin, Zhu, Li, Tang, Rong, Ye, Huayue, Lin, Mei, Ge, Lei, Wang, Xiyuan, Peng, Fuzhong, Wu, Zhenggang, Guo, Xiling, Shi, Yunfeng, Pan, Hongxing, Zhu, Jiahong, Song, Zhizhou, Qiu, Jingjun, Wang, Wei, Zheng, Jianfei, Ozhelvaci, Orkun, Shpyro, Svetlana, Bushway, Meghan, Derhovanessian, Evelyna, Kühnle, Marie-Cristine, Luxemburger, Ulrich, Muik, Alexander, Shishkova, Yoana, Khondker, Zakaria, Hu, Simin, Lagkadinou, Eleni, Şahin, Uğur, Türeci, Özlem, Zhu, Fengcai
Publicado 2022